International Clinical Trial: A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204314) titled 'A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder' on Sept. 30.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Takeda

Condition: Major Depressive Disorder

Intervention: Drug: Vortioxetine tablets

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 1, 2025

Target Sample Size: 180

To know more, visit https://clinicaltrials.gov/study/NCT07204314

Published by HT Digital Content...